prostate cancer | Medivizor | source: Medivizor | Added Jan 22, 2020
Positive Thinking and Cancer-Myth-Making
Called the "Emperor of All Maladies." there's little doubt that a cancer diagnosis throws life completely out of control. Unfortunately, this chaos creates vulnerabilities that can and have been exploited. It is tempting to believe the idea that if you control your thoughts and make them positive, you can controlprostate cancer | Medivizor | source: Medivizor | Added Jan 20, 2020
Quick Guide: Understanding the Importance of the FDA's Keytruda Approval
In July 2015, we published a post called Patients Included In Research: Studying Cancer by Mutation Not Organ. In that post, we shared the goal that cancers would be treated not by the site of origin, but rather by their genetic features. Achieving this goal is closer than you think!prostate cancer | Medivizor | source: Medivizor | Added Jan 18, 2020
Infographic on Cancer Immunotherapy
Last summer we provided a series of posts on oncology basics. Oncology Basics: Preparing for ASCO covered some of the history of oncology. In Understanding Cells, we reviewed what is newly understood about cells--it's way beyond what you learned in high school biology. DNA with lots of animated videos also explained some
prostate cancer | Research | Treatment | 10 pages | source: The Lancet. Oncology | Added Jan 15, 2020
Quality of life in patients with advanced prostate cancer after apalutamide treatment
This study analyzed the health-related quality of life (HRQOL) in patients with metastatic castration-sensitive prostate cancer (MCSPC) after treatment with apalutamide (Erleada) and androgen deprivation therapy (ADT). The study found that apalutamide plus ADT was well tolerated and improved survival compared to ADT alone in these patients.
prostate cancer | Medivizor | source: Medivizor | Added Jan 13, 2020
How to Smoothie!
This summer has been a challenge after a family member with celiac disease had a gluten exposure (Click here to read more about celiac disease). Gluten damages the small intestine villi (see 5 Facts You Probably Didn't Know About Your Small Intestines), which are essential for nutrition absorption. For overprostate cancer | Medivizor | source: Medivizor | Added Jan 11, 2020
15 Tips to Cope with Scanxiety (Scan Anxiety)
"Keep Calm And Carry On:" Really? “The shock of that day you hear the words, ‘you have cancer’ never leaves you and your sense of certainty in life and in your body can be hard to recapture after a diagnosis of cancer.”-Marie Ennis-O'Connor After Surgery, Chemo, Radiation This is the
prostate cancer | Research | Treatment | 8 pages | source: Cancer | Added Jan 07, 2020
Evaluating bone density testing in prostate cancer patients treated with hormone therapy
The study assessed the frequency of bone density testing among prostate cancer patients treated with androgen-deprivation therapy.
prostate cancer | Medivizor | source: Medivizor | Added Jan 02, 2020
Cancer Patient Resources: Free Air Travel
Cost Medical care for cancer is costly. In addition, there is the financial burden that patients and families face in getting to and from the best care--which may be located at medical centers far from home. The situation can seem overwhelming. Corporate Angel Network Into this dilemma, little known resourcesprostate cancer | Research | Treatment | 10 pages | source: Targeted oncology | Added Dec 31, 2019
Abiraterone acetate and prednisone in patients with metastatic, castration‑sensitive prostate cancer
This study evaluated if the benefit of adding abiraterone acetate (Zytiga) + prednisone (Deltasone) to androgen-deprivation therapy (ADT) in treating metastatic, castration-sensitive prostate cancer (mCSPC) would be maintained in patients treated with ADT alone. This study concluded that this treatment improved patients’ survival in these patients.
